Stempoint Capital »

Autolus Therapeutics Plc spon ads shares owned by Stempoint Capital

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.3M 2.7M 3.48
2024-03-31 $21M 3.2M 6.38

More positions owned by Stempoint Capital

Syndax Pharmaceuticals (SNDX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Merus N V (MRUS)
Arcellx Common Stock (ACLX)
Amicus Therapeutics (FOLD)
Immunocore Hldgs Ads (IMCR)
Applied Therapeutics (APLT)
Merck & Co (MRK)
GSK Sponsored Adr (GSK)
Autolus Therapeutics Spon Ads (AUTL)
Cabaletta Bio (CABA)
Kalvista Pharmaceuticals (KALV)
Biohaven (BHVN)

View all positions for Stempoint Capital

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Deep Track Capital
venBio Select Advisor
Wellington Management Company
FMR
Polygon Management
Armistice Capital
Frazier Life Sciences Management
BlackRock
T. Rowe Price Associates
Affinity Asset Advisors
Laurion Capital Management
Deerfield Management Company
Dr. Jeffrey R. Jay, M.D.

View all funds holding Autolus Therapeutics Plc spon ads